Graft-versus-host disease and immunosuppression

被引:1
作者
Kapoor, Neena [1 ,2 ]
机构
[1] Childrens Hosp Los Angeles, Clin Hematopoiet Stem Cell Transplant Program, Los Angeles, CA 90027 USA
[2] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
关键词
D O I
10.1007/s12026-007-0026-y
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:34 / 44
页数:11
相关论文
共 27 条
  • [1] Billingham R E, 1966, Harvey Lect, V62, P21
  • [3] Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Cutler, C
    Henry, NL
    Magee, C
    Li, SL
    Kim, HT
    Alyea, E
    Ho, V
    Lee, SJ
    Soiffer, R
    Antin, YH
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (07) : 551 - 557
  • [4] Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
    Davies, SM
    DeFor, TE
    McGlave, PB
    Miller, JS
    Verfaillie, CM
    Wagner, JE
    Weisdorf, DJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 2001, 110 (05) : 339 - 346
  • [5] Graft-versus-host disease: How to translate new insights into new therapeutic strategies
    Devetten, MP
    Vose, JM
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (12) : 815 - 825
  • [6] Pathogenesis of acute graft-versus-host disease: Cytokines and cellular effectors
    Ferrara, JLM
    [J]. JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (03): : 299 - 306
  • [7] FLOMENBERG N, 2001, BLOOD, V98, P2942
  • [8] FLOWERS MED, 2002, BLOOD MARROW TRANSPL, V12, P5
  • [9] GATTI RA, 1968, LANCET, V2, P1366
  • [10] Hydroxychloroquine for the treatment of chronic graft-versus-host disease
    Gilman, AL
    Chan, KW
    Mogul, M
    Morris, C
    Goldman, FD
    Boyer, M
    Cirenza, E
    Mazumder, A
    Gehan, E
    Cahill, R
    Frankel, S
    Schultz, K
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 327 - 334